Sign in Pull a receipt

AURA

Aura Biosciences, Inc.

Healthcare · Biotechnology

$292.39 sample

+1.13 (+0.39%) 1D

Market cap

$1.23T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-26

Alerts

8

Price$292.39 +7.98% 3M daily closessample

301.43270.58

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26SECDEF 14A filed
Oct 15INSInsider buy: Director
Oct 08INSInsider sell: Director
Oct 02INSInsider sell: EVP, Operations
Sep 23INSInsider buy: Chief Executive Officer
Sep 15SECForm 144 filed
Sep 08INSInsider buy: Director
Sep 01INSInsider sell: Chief Financial Officer

Sign up to see the real AURA record →

Company facts

SEC EDGAR registration

Name: Aura Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +38sample, -100 to +100
Reporting currency: USD

Who is positioning in AURA

sample

Insiders: 15 insider transactions over 90 days, net selling, $648.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 16 funds hold $6.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$74.3B +24.5% y/y

Q4 2024Q3 2026

Inventory$43.5B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$33.3B +12.9% y/y

Q4 2024Q3 2026

Total debt$82.4B +4.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.13T -8.1% 3M
Sample peer B: $799.4B +14.2% 3M
Sample peer C: $1.21T +1.8% 3M
Sample peer D: $924.4B +8.0% 3M
Sample peer E: $586.1B +13.9% 3M